An interesting report of Gefitinib induced differentiation in AML cell lines and AML patient samples [51], spurred preclinical studies that reported pro apoptotic and anti-mitotic effects of erlotinib in EGFR negative MDS and AML cell lines [52]. This evidence concerns the gene EGFR and acute myeloid leukemia.